Lv2
126 积分 2024-04-22 加入
Immune checkpoint inhibitor-related dermatologic adverse events
15天前
已完结
IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planus
15天前
已完结
Efficacy and Safety of Human Skin Microbiome-Derived Strains as Topical Treatment for Acne: An In Vitro and In Vivo Study
22天前
已完结
Proteasome Inhibitors Interact Synergistically with BCL2, Histone Deacetylase, BET, and Jak Inhibitors against Cutaneous T-Cell Lymphoma Cells
28天前
已完结
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
28天前
已完结
Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib
28天前
已完结
A 10-year retrospective cohort study of ruxolitinib and association with nonmelanoma skin cancer in patients with polycythemia vera and myelofibrosis
1个月前
已完结
Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis
1个月前
已完结
Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease
1个月前
已完结
皖公网安备34019202002308
